Literature DB >> 2181704

Pathophysiology of portal hypertension and variceal bleeding.

T C Mahl1, R J Groszmann.   

Abstract

Portal hypertension results from an interaction of abnormal intrahepatic resistance and increases in portal blood flow. Intrahepatic resistance is probably multifactorial in nature and may include compression of hepatic veins by regenerating nodules, collagen deposition in sinusoids and venules, hepatocyte enlargement, and constriction of sinusoids by contractile myofibroblasts. The increase in splanchnic blood flow observed is incompletely understood, but it may involve circulating vasodilators and alteration in volume and sodium balance. The end result of these interactions is the development of increased portal pressure and portosystemic collaterals, the most important of which are esophageal varices. The rupture of esophageal varices is a devastating complication of portal hypertension. Increased portal pressure is necessary for the development and rupture of varices but apparently not sufficient, because many patients with elevated portal pressures never bleed. Presumably, local factors must be involved. Variceal wall tension is probably the best single descriptor of risk from variceal hemorrhage. The wall-tension formula unites the contributions of portal pressure, varix size, and wall thickness to variceal rupture. Lowering portal pressure, reducing varix size, and supporting varices in scar tissue may all lower the risk of hemorrhage.

Entities:  

Mesh:

Year:  1990        PMID: 2181704     DOI: 10.1016/s0039-6109(16)45080-2

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  9 in total

1.  Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging.

Authors:  Hervé Gouya; Sophie Grabar; Olivier Vignaux; Anastasia Saade; Stanislas Pol; Paul Legmann; Philippe Sogni
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

2.  CT portography with gastric variceal volume measurements in the evaluation of endoscopic therapeutic efficacy of tissue adhesive injection into gastric varices: a pilot study.

Authors:  John P Rice; Meghan Lubner; Andrew Taylor; Bret J Spier; Adnan Said; Michael R Lucey; Alexandru Musat; Mark Reichelderfer; Patrick R Pfau; Deepak V Gopal
Journal:  Dig Dis Sci       Date:  2011-02-19       Impact factor: 3.199

Review 3.  Surgical management of portal hypertension.

Authors:  J C Collins; I J Sarfeh
Journal:  West J Med       Date:  1995-06

4.  Hemodynamic effects of hypothyroidism induced by methimazole in normal and portal hypertensive rats.

Authors:  R Oren; N Hilzenrat; Y Maaravi; A Yaari; E Sikuler
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

Review 5.  Inflammation: a way to understanding the evolution of portal hypertension.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Arturo Cruz; Jaime Arias
Journal:  Theor Biol Med Model       Date:  2007-11-13       Impact factor: 2.432

6.  Impact of Helicobacter pylori Infection on Gastric Variceal Bleeding among Patients with Liver Cirrhosis.

Authors:  Mohamed A Elsebaey; Mohamed A Tawfik; Samah A Elshweikh; Manal Saad Negm; Mohammed H Elnaggar; Ghada Mahmoud Alghazaly; Sherief Abd-Elsalam
Journal:  Gastroenterol Res Pract       Date:  2019-02-10       Impact factor: 2.260

7.  Relationship between hemodynamic parameters and portal venous pressure in cirrhosis patients with portal hypertension.

Authors:  Hongjuan Yao; Yongliang Wang
Journal:  Open Life Sci       Date:  2020-12-31       Impact factor: 0.938

Review 8.  The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Jaime Arias
Journal:  J Transl Med       Date:  2007-09-24       Impact factor: 5.531

9.  Relationship of hemodynamic indices and prognosis in patients with liver cirrhosis.

Authors:  Soon Koo Baik; Myeong Gwan Jee; Phil Ho Jeong; Jae Woo Kim; Sang Won Ji; Hyun Soo Kim; Dong Ki Lee; Sang Ok Kwon; Young Ju Kim; Joong Wha Park; Sei Jin Chang
Journal:  Korean J Intern Med       Date:  2004-09       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.